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During evolution, many new proteins have been
formed by the process of gene duplication and
combination. The genes involved in this pro-
cess usually code for whole domains. Small
proteins contain one domain; medium and large
proteins contain two ormore domains.We have
compared homologous domains that occur in
both one-domain proteins and multidomain
proteins. We have determined (1) how the func-
tions of the individual domains in the multido-
main proteins combine to produce their overall
functions and (2) the extent towhich these func-
tions are similar to those in the one-domain
homologs. We describe how domain combina-
tions increase the specificity of enzymes; act
as links between domains that have functional
roles; regulate activity; combine within one
chain functions that can act either indepen-
dently, in concert or in new contexts; and pro-
vide the structural framework for the evolution
of entirely new functions.
INTRODUCTION
During the course of evolution, the process of gene dupli-
cation, sequence divergence, and gene combination has
produced many proteins that have new or modified
functions. A number of previous studies have described
in detail how gene duplication and sequence divergence
produce proteins with new properties. Gerlt and Babbitt
(2001) have reviewed their work on enzymes that belong
to mechanistically diverse superfamilies (those that con-
serve some part of their catalytic mechanism) and to
functionally distinct superfamilies (those that do not con-
serve a common mechanism). Nahum and Riley (2001) de-
scribed how sequence divergence in families of E. coli
proteins has produced proteins with different functions.
Todd et al. (2001) in a detailed study of enzymes in 31 su-
perfamilies described point mutations and local structural
changes that occur within homologous domains to modify
their functions. They also studied 22 pairs of homologous
proteins in which one protein is an enzyme and one is not
(Todd et al., 2002). Bartlett et al. (2003) made a detailedStructure 15, 8analysis of catalytic residue conservation and variation in
27 pairs of enzymes that are homologous but have very
different functions.
Although there have been detailed investigations of the
roles that duplication and sequence divergence play in
producing proteins with new functions, far less attention
has been paid to the role of gene combination. Hegyi
and Gerstein (2001) compared the enzyme commission
(EC) numbers and SWISS-PROT keywords of one-domain
proteins with those of multidomain proteins that included
homologs of the domain in the one-domain protein. They
did not however discuss how separate functions of do-
mains combine to create the functions of a whole protein.
The units that are usually involved in combination are
the genes, or gene segments, that code for protein do-
mains. Small proteins are formed by a single domain.
Most proteins are formed by two or more domains.
Here, we consider 45 sets of proteins. Each set contains
one or more one-domain protein and a protein with two or
more domains. The one-domain proteins are homologous
to one or more of the domains in the multidomain member
of the set. For the proteins in these sets, the functions and
structures of both the one-domain and multidomain pro-
teins have been well characterized. In all cases, the multi-
domain protein has a function that is more specific or more
complex than that of the one-domain protein. By an exam-
ination of the functions and structures of each pair, we de-
termine, at least in outline, the main contribution that gene
combination makes to the more specific or more complex
functions of the multidomain proteins.
The descriptions given here are not, of course, com-
plete descriptions of the contributions that each domain
makes to the functions of the multidomain protein. Even
if the proteins were characterized well enough for us to
do this, a complete description would require a paper on
each set of structures. Here, we determine the major con-
tributions and roles made by each domain to the function
of the multidomain protein, and how these are the same
as, or different from, the functions found in the one-
domain homologs.
A LIBRARY OF PROTEINS WITH HOMOLOGOUS
DOMAINS IN ONE-DOMAIN AND TWO- OR MORE
DOMAIN PROTEINS
The domain definitions used in this study are taken from
the Structural Classification of Proteins (SCOP) database5–99, January 2007 ª2007 Elsevier Ltd All rights reserved 85
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Genesis of New Functions via Domain CombinationTable 1. The 45 Sets of One-Domain and Multidomain Proteins that Contain Homologous Domains
Number One-Domain Protein(s) Multidomain Proteins
Functional Modification/
Conservation
1 Glucoamylas 1ayx 3.2.1.3 Endo/exocellulase:cellobiose
E-4 1js4 3.2.1.4
1a C
_ b.2.2 _
2 b-amylase 1bfn 3.2.1.2 b-amylase 1b90 3.2.1.2 1a C
_ b.3.1 _
3 Bacterial phospholipase C 1ah7 3.1.4.3 a-toxin 1ca1 3.1.4.3 1a C
_ b.12.1 _
4 Guanylate kinase 1ex7 2.7.4.8 Adenylate kinase 1ak2 2.7.4.3 1a C
_ g.41.2 _
5a Glycinamide ribonucleotide
transformylase (GART)
1jkx 2.1.2.2
Methionyl-tRNAfmet formyltransferase
2fmt 2.1.2.9
1a C
5b 3-methyladenine DNA glycosylase
1ewn 3.2.2.21
Methionyl-tRNAfmet formyltransferase
2fmt 2.1.2.9
5 P
6a Asparagine synthetase 12as 6.3.1.1 Aspartyl-tRNA synthetase (AspRS)
1asy 6.1.1.12
1a C
6b ssDNA-binding protein 1eyg Aspartyl-tRNA synthetase (AspRS)
1asy 6.1.1.12
1b C
7 RNA methyltransferase FtsJ
1ej0 2.1.1.-
Chemotaxis receptor methyltransferase
1af7 2.1.1.79
1a C
_ a.58.1 _
8 Lysozyme 1lys 3.2.1.17 Lytic transglycosylase Slt70
1qsa 3.2.1.-
1a C
_ a.118.5 _
9 Kanamycin nucleotidyltransferase
(KNTase) 1kny 2.7.7.-
DNA polymerase b 1bpd 2.7.7.7 1a C
_ a.60.6 _
10 g-glutamyl hydrolase 1l9x 3.4.19.9 Carbamoyl phosphate synthetase small
subunit 1a9x 6.3.5.5 (Whole complex)
1a C
_ c.8.3 _
11 Proline iminopeptidase 1azw 3.4.11.5 Prolyl oligopeptidase 1e5t 3.4.21.26 1a C
_ b.69.7 _
12 Tryptophanyl-tRNA synthetase
1m83 6.1.1.2
Methionyl-tRNA synthetase 1a8h
6.1.1.10
1a C
_ a.27.1 _
13a Tryptophanyl-tRNA synthetase
1m83 6.1.1.2
Glutaminyl-tRNA synthetase
1euq 6.1.1.18
1a C
13b Ribosomal protein L25 1dfu Glutaminyl-tRNA synthetase
1euq 6.1.1.18
1b C
14 Mitochondrial cytochrome c6 1c75 Cytochrome cd1 1aof 1.9.3.2 1b C
_ b.70.2 _
15a Soluble, respiratory-type Rieske
protein 1nyk
Naphthalene 1,2-dioxygenase a subunit
1eg9 1.14.12.12
1b C
15b Phoshatidylinositol transfer protein
(PITP) 1fvz
Naphthalene 1,2-dioxygenase a subunit
1eg9 1.14.12.12
6 N
16 Plastocyanin 1pcs Nitrous oxide reductase 1qni 1.7.99.6 1b C
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Genesis of New Functions via Domain CombinationTable 1. Continued
Number One-Domain Protein(s) Multidomain Proteins
Functional Modification/
Conservation
17a Flavodoxin 1ag9 Ruberdoxin: oxygen oxidoreductase 1e5d 1b C
17b Zn metallo-b-lactamase 1dxk 3.5.2.6 Ruberdoxin: oxygen oxidoreductase 1e5d 7 N
18 Ferredoxin II 1fxd Iron hydrogenase large (catalytic)
subunit 1hfe 1.18.99.1
1b C
_ c.96.1 _
19a Ruberdoxin 1rb9 Rubrerythrin 1b71 1b C
19b Bacterioferritin (cytochrome b1) 1bcf Rubrerythrin 1b71 6 N
20 Carboxypeptidase A 1f57 3.4.17.1 Peptidase T 1fno 3.4.11.4 1c C
_ d.58.19 _
21a b-glucanase 1ghs 3.2.1.39 b-glucuronidase 1bhg 3.2.1.31 1d C
21b Fucose-binding lectin 1k12 b-glucuronidase 1bhg 3.2.1.31 4 N
21c Glactose mutarotase 1nsx 5.1.3.3 b-galactosidase 1jz7 3.2.1.23 4 N
_ b.1.4 _
22 b-lactamase 1erm 3.5.2.6 Penicillin-recognizing enzyme
1ei5 3.4.11.19
1d C
_ b.61.3 _
23 Dual-specificity protein phosphatase
VHR (vhr) 3.1.3.48
Tyrosine phosphatase 2shp 3.1.3.48 1e C
_ d.93.1 _
24 B12-dependent (class II) ribonucleotide
reductase 1l1l 1.17.4.2
R1 subunit of ribonucleotide reductase.
Catalyzes the synthesis of
deoxyribonucleotides 1r1r 1.17.4.1
1e C
_ a.98.1 _
25a MARR antibiotic-resistance
repressor 1jgs
Molybdate-dependent transcriptional
regulator ModE 1b9m
1f C
25b Molybdate/tungstate-binding protein II
1gug
Molybdate-dependent transcriptional
regulator ModE 1b9m
4 C
26a Bacteriophage lambda repressor 1mb Purine repressor (PurR) 1bdh 1f C
26b Ribose-binding protein 2dri Purine repressor (PurR) 1bdh 4 N
27a Penicillin V acylase 2pva 3.5.1.11 Asparagine synthetase B 1ct9 6.3.5.4 2 C
27b NH3-dependent NAD+-synthetase
1kqp 6.3.5.1
Asparagine synthetase B 1ct9 6.3.5.4 2 C
28a Xanthine-guanine PRTase 1nul 2.4.2.22 Glutamine 5-phospho-ribosyl-1-
pyrophosphate (PRPP)
amidotransferase 1ecc 2.4.2.14
2 C
28b Putative glutamine amidotransferase
1te5
Glutamine 5-phospho-ribosyl-1-
pyrophosphate (PRPP)
amidotransferase 1ecc 2.4.2.14
2 C
29a Trypsin 1 1trn 3.4.21.4 NS3 protease 1cu1 3.4.21.- 2 C
29b Guanylate kinase 1ex7 2.7.4.8 NS3 protease 1cu1 3.4.21.- 2 N
30a UDP-N-acetylglucosamine
acyltransferase 1lxa 2.3.1.129
N-Acetylglucosamine-1-PO4
uridyltransferase (GlmU)
1hv9 2.3.1.157 and 2.7.7.23
2 C
30b Uridyl transferase 1jvd 2.7.7.23 N-Acetylglucosamine-1-PO4
uridyltransferase (GlmU)
1hv9 2.3.1.157
and 2.7.7.23
2 C
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Number One-Domain Protein(s) Multidomain Proteins
Functional Modification/
Conservation
31a RNase H 1ril 3.1.26.4 DNA polymerase II 1d5a 2.7.7.7 2 C
31b Bacteriophage T7 RNA Polymerase
1msw 2.7.7.6
DNA polymerase II 1d5a 2.7.7.7 2 C
32a Phosphoribulokinase 1a7j 2.7.1.19 6-phosphofructo-2-kinase/fructose-
2,6-bisphosphatase 1bif 2.7.1.105
and 3.1.3.46
2 C
32b Prostatic acid
phosphatase 1nd6 3.1.3.2
6-phosphofructo-2-kinase/fructose-
2,6-bisphosphatase 1bif 2.7.1.105
and 3.1.3.46
2 C
33a FHIT (fragile histidine triad protein)
1fit 3.6.1.29
NitFhit fusion protein 1ems 3.6.1.29 2 C
33b N-carbamoyl-D-amino acid
amidohydrolase 1uf5 3.5.1.77
NitFhit fusion
protein 1ems 3.6.1.29
2 N
34a I-CreI 1bp7 PI-SceI 1dfa 2 C
34b GyrA intein am2 PI-SceI 1dfa 2 C
35a Cro lambda
repressor 5cro
SinR repressor 1b0n 3 P
35b SinI antirepressor 1b0n SinR repressor 1b0n 8 C
36a Drosophila (short chain) alcohol
dehydrogenase 1b16 1.1.1.1
Alcohol dehydrogenase 1a71
1.1.1.1
3 P
36b Chaperonin-10 (GroES) 1aon Alcohol dehydrogenase 1a71
1.1.1.1
6 N
37a EcoRV 1rva 3.1.21.4 Restriction endonuclease (FokI)
1fok 3.1.21.4
3 C
37b MARR antibiotic-resistance
repressor 1jgs
Restriction endonuclease (FokI)
1fok 3.1.21.4
1b C
38a Hah1 Metallochaperone 1fe0 Copper chaperone of superoxide
dismutase (CCS) 1qup
3 P
38b Cu, Zn superoxide dismutase (SOD)
1cbj
Copper chaperone of superoxide
dismutase (CCS) 1qup
5 P
39 [2Fe-2S] ferredoxin 1czp Iron protein from quinol-fumarate
reductase. (Binds iron clusters
in the fumarate reductase complex)
1fum 1.3.99.1
4 C
_ a.1.2 _
40a Glycolate oxidase 1al8 1.1.3.15 Flavocytochrome b2 1fcb 1.1.2.3 4 C
40b Cytochrome b5 1cyo Flavocytochrome b2 1fcb 1.1.2.3 4 C
41a Ribosomal protein L24 1jj2 Ribosomal protein L2 1ffk 4 C
41b Single-stranded DNA-binding protein
1eyg
Ribosomal protein L2 1ffk 4 C
42 Ribosomal protein S9 1j5e Ribosomal protein S5 1j5e 4 C
_ d.50.1 _
43 FK-506-binding protein (FKBP12)
1fkh 5.2.1.8
GreA transcript cleavage factor 1grj 5 N
_ a.2.1 _
44 Pyruvoyl-dependent aspartate
decarboxylase (ADC) 1aw8 4.1.1.11
Formate dehydrogenase H
1aa6 1.2.1.2
5 N
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Number One-Domain Protein(s) Multidomain Proteins
Functional Modification/
Conservation
45a Threonine synthase 1e5x 4.2.3.1 Allosteric threonine deaminase
1tdj 4.2.1.16
7 P
45b Putative glycine cleavage system
repressor 1u8s
Allosteric threonine deaminase
1tdj 4.2.1.16
4 P
In cases in which there is more than one known single-domain homolog for a domain combination, the different pairs are separated
out with the letters a, b, and c. Where no homologous single-domain protein is available, a ‘‘_’’ is noted and the SCOP superfamily is
given. The names and PDB codes as well as enzyme commission (EC) numbers (in italics) are given where available. The type of
functional modification is given for each pair in the final column and corresponds to those listed in Table 2. Also, the state of func-
tional conservation from the single-domain environment to the multidomain protein for a particular homologous domain is given as
‘‘C’’ for conserved; ‘‘N’’ for nonconserved; and ‘‘P’’ for partial conservation.(Murzin et al., 1995). In the SCOP classification scheme,
a domain is an evolutionary unit, rather than a structural
one. This means that for a protein to be split into domains
these regions must be seen elsewhere in a different struc-
tural context: they must be found in combination with dif-
ferent domains and/or in isolation.
SCOP domains are classified into families (evolutionary
relationship shown by residue identity) and superfamilies
(evolutionary relationship shown by features of their struc-
ture, function, and sequence). Here, we use domains clas-
sified at the superfamily level. In SCOP, the superfamilies
of domains are identified by labels that take the form of
c.2.1: the first character identifies the class of the protein,
the second character identifies the fold, and the third char-
acter indicates the particular superfamily. Our work is
based on the 1.65 version of the SCOP database.
To create our data set, we first collected a list of all pro-
teins in SCOP that contained at least two domains that
come from different superfamilies. Proteins have the
same domain architecture when they have domains from
the same superfamilies in the same sequential order.
From this list, one representative structure was chosen
to represent each domain architecture: usually the one
whose function is the best characterized. This resulted in
a list of 172 multidomain proteins. The domains in these
proteins belong to 1 of 255 superfamilies. For each of
these superfamilies, SCOP was then searched for the
presence of a functional one-domain homolog that is not
a fragment of a larger protein. Where there were several
one-domain homologs, we chose the one whose function
is closest to that in the multidomain protein. Of the 255
superfamilies present in the two-domain proteins, 83
had a corresponding one-domain homolog.
We then initially searched for descriptions for the func-
tions of the one-domain proteins and their homologs in the
multidomain protein by reading the primary literature listed
in the protein data bank PDB entry (Berman et al., 2000) for
that structure. This was followed by a literature search to
retrieve functional information produced since structural
determination. In some cases, details of the function of
a domain in the multidomain protein and/or the one-
domain protein(s) are not known. However, there were
45 sets of proteins for which we could attribute functionsStructure 15,to each domain in the multidomain protein and to the
one-domain protein(s) that is homologous to one or
more of the domains in multidomain protein.
PRESENTATION OF THE RESULTS
In Table 1, we list the one-domain and multidomain pro-
teins in the 45 sets. All but one of the sets has one multi-
domain protein that is formed by domains from two super-
families. Of these, 23 have one-domain proteins that
belong to both of the superfamilies that form the multido-
main protein. Another 21 sets have a single one-domain
protein that belongs to one of the superfamilies in the
multidomains proteins: members of the other superfam-
ilies are, at present, only observed in domain combina-
tions. There is one set with two related multidomain
proteins whose domains come from four superfamilies
(entry 21 in Table 1): one-domain homologs are known
for three of these superfamilies.
For one-domain proteins and multidomain proteins of
known structure, we give the full name of the protein
and the PDB code of a representative structure. For the
21 domains in the multidomain proteins for which no
one-domain homolog is currently known, we give the
SCOP identifier of its superfamily.
When homologs of one-domain proteins combine with
other domains to form multidomain proteins, their func-
tions are modified or changed. The comparison of the
functions of the one-domain protein(s) and its homolog
in multidomain proteins in the 45 sets allows us to assign
their functional modification to 1 of 7 types: see Table 2.
Below, we discuss and illustrate examples of the 7 types,
as seen in 11 of the 45 sets. In Table 1, we indicate the
nature of the changes that occur in all sets; in the Supple-
mental Data available with this article online, an expanded
version of Table 1 (Table S1) gives further details of these
changes.
In this paper, we always refer to the multidomain protein
as having a function that is changed, modified, or copied
from that found in the one-domain protein. We believe
that going from the simple to the complex is the most plau-
sible scenario. We do not, of course, believe that the op-
posite process never occurs. The central interest of this85–99, January 2007 ª2007 Elsevier Ltd All rights reserved 89
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Genesis of New Functions via Domain CombinationTable 2. The Seven Types of Functional Modifications Produced by Domain Combinations
Functional Modification Quantity
1. Proteins whose functions are modified by additional domains:
a. domains that modify substrate binding 13
b. domains that are catalytic 9
c. domains that modify substrate binding through the formation of oligomers 1
d. domains that link domains that have a direct role in function 2
e. domains that regulate enzyme function 2
f. domains that regulate DNA binding 2
2. Gene fusions that form bifunctional enzymes 16
3. Transfer of a function to an additional domain 4
4. Domains whose combination allows them to function in new contexts 11
5. Loss of catalytic function by a homolog in a domain combination 4
6. Gain of a catalytic activity in a domain combination 3
7. Change in catalyzed reaction in domain combination 2
Domain that conserves its dimerization property (not a modification) 1
Total 70paper is how combinations of domains have functions that
are different or similar to those in one-domain proteins,
and the direction in which their evolution has taken place
does not qualify these relationships.
ENZYMATIC DOMAINS THAT LARGELY
CONSERVE THEIR CATALYTIC PROPERTIES
IN DOMAIN COMBINATION BUT HAVE THEIR
FUNCTIONS MODIFIED BY OTHER DOMAINS
In this section, we discuss cases in which a one-domain
enzyme and a multidomain enzyme both have homo-
logous catalytic domains that largely conserve their func-
tion. The additional domains in the multidomain enzyme
assist with substrate binding or modulate the function of
the catalytic domain in some other way. We consider
enzymatic functions to be largely conserved when they
meet one of two criteria:
1. the EC numbers are available for both proteins, and
at least the first three EC numbers are the same;
2. they carry out the same reaction, e.g., transfer of
a NH2 group, on a related but different substrate(s).
We have chosen to introduce the second criterion, as it
is known that proteins with dissimilar EC numbers can
have similar reactions (Gerlt and Babbitt, 2001; Nahum
and Riley, 2001).
In most of the enzymes discussed in this section, the
one-domain protein and its homologous domain in combi-
nation with other domains have related substrates, related
reaction chemistry, and the same first three EC numbers.
We breakdown the cases in this category into separate
subcategories depending on the way in which the addi-
tional domains modulate the function of the conserved
catalytic domain.90 Structure 15, 85–99, January 2007 ª2007 Elsevier Ltd All righDomains that Modify Substrate Binding:
Figure 1 and Entry 6
In this large subcategory, there are 13 cases of homologs
of one-domain enzymes that catalyze the same or a similar
reaction but have their substrate specificity modified or
extended by an additional domain: see Table 1, entries
1–13.
Asparagine Synthetase and Aspartyl-tRNA
Synthetase
Example of an additional domain extending the substrate-
binding properties of a catalytic domain are found in the
one-domain enzyme asparagine synthetase (Nakatsu
et al., 1998) and the two-domain enzyme aspartyl-tRNA
synthetase (Ruff et al., 1991). Both enzymes have homol-
ogous catalytic domains that are members of the ‘‘Class II
aaRS and biotin synthetases superfamily’’ (d.104.1).
In addition, the synthetase has an N-terminal domain
that is a member of the nucleic acid-binding proteins
superfamily (b.40.4). This domain is mainly responsible
for the specificity of the synthetase for tRNAAsp (Figure 1).
Other members of the superfamily bind single-standard
DNA and play important roles in DNA replication and
recombination.
The one-domain protein asparagine synthetase cata-
lyzes the synthesis of asparagine from aspartic acid via
an aminoacyl-adenylate intermediate produced by ATP
and ammonia (Nakatsu et al., 1998). The catalytic C-termi-
nal domain of aspartyl-tRNA synthetase also uses an
aminoacyl-adenylate intermediate to bind aspartic acid
to an NH2 group of the terminal nucleotide of tRNA
Asp.
Though the reaction of both catalytic domains is very sim-
ilar, they differ in that aspartyl-tRNA synthetase amidates
the a-carboxylate group, while asparagine synthetase
amidates the b-carboxylate group. Inspection of the active
sites in the two enzymes shows that they have very similarts reserved
Structure
Genesis of New Functions via Domain Combinationstructures and carry out their reactions in the same man-
ner, except for small differences in active site residues
that direct the amino group to different carboxylates
(Nakatsu et al., 1998).
Thus, here the single-stranded nucleic acid recognition
function of the N-terminal domain is conserved and is
used to give a new specificity to a catalytic domain whose
mechanism has been only slightly modified.
Domain that Modulates Function through the
Formation of Oligomers and Intersubunit
Contacts: Figure 2 and Entry 20
There is one case in our data set (entry 20) where a
one-domain enzyme has a homologous domain in a
two-domain protein in which the additional domain leads
to the formation of a dimer and hence, through interactions
between the subunits, a modification of the specificity.
Carboxypeptidase A and Peptidase T
Carboxypeptidase A is a one-domain protein (Rees et al.,
1983), and peptidase T has two domains (Hakansson and
Miller, 2002). Both enzymes have catalytic domains that
are members of the ‘‘Zn-dependent exopeptidases’’
Figure 1. Yeast Aspartyl-tRNA Synthetase 1azs
The N-terminal domain of the ‘‘Nucleic acid-binding proteins’’ super-
family (b.40.4) is shown in orange, and the catalytic C-terminal domain
of the ‘‘Class II aaRS and biotin synthetases’’ superfamily (d.104.1) is
shown in blue. The tRNAAsp molecule is shown in space-filling repre-
sentation in gray. ATP bound in the enzyme active site is shown in
green. This figure was drawn from 1azs (Ruff et al., 1991).Structure 15,superfamily (c.56.5). The second domain in peptidase T
is a member of the ‘‘bacterial exopeptidase dimerization
domain’’ superfamily (d.58.19). Pairs of the additional
domains bind together to make the protein a dimer (see
Figure 2).
Carboxypeptidase A catalyzes the hydrolysis of C-ter-
minal amino acids from polypeptide substrates. The activ-
ity of peptidase T is more specific: it will only hydrolyze
tripeptides at an unblocked N terminus, and it will not
hydrolyze longer polypeptides, unlike carboxypeptidase
A. Inspection of the structure of peptidase T shows that
the active sites in the two catalytic domains in the dimer
are restricted by residues from their own additional do-
main and by residues from the symmetry-related addi-
tional domain. These residues come from the ‘‘bottom’’
of the additional domain in their own monomer and
from the ‘‘top’’ of the domain in the symmetry-related
monomer (see Figure 2). The presence of these additional
residues in the active site of the enzyme reduces the
space around the substrate-binding site (Hakansson and
Miller, 2002).
Figure 2. The Peptidase T Dimer from S. typhimurium 1fno
The catalytic domains of the ‘‘Zn-dependent exopeptidases’’ super-
family (c.56.5) are shown in light and dark blue, and the dimerization
domains of the ‘‘Bacterial exopeptidase dimerization domain’’ super-
family (d.58.19) are shown in orange and yellow. The active site region
in one chain containing two zinc ions is circled in green. Substrate
binding is contributed to by the catalytic domain and both dimerization
domains. This figure was drawn from 1fno (Rees et al., 1983).85–99, January 2007 ª2007 Elsevier Ltd All rights reserved 91
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(A–C) (A) (1/3)-b-glucanase (Varghese et al., 1994) represents the basic ‘‘(Trans) glycosidases’’ superfamily (c.1.8). Homologous catalytic domains
are found in (B) b-glucuronidase and (C) b-galactosidase. (B) In b-glucuronidase (Jain et al., 1996), the catalytic domain is 3 (in red) and is joined by two
other domains: 1 restricts the binding site, and 2 links 1 to 3. (C) b-galactosidase. The first three domains have the same structure as b-glucuronidase
(Jacobson et al., 1994). Domain 4 links domain 3 to 5, which contributes to the active site.Domains that Link Other Domains that Have a Direct
Role in Function: Figures 3A–3C and Entry 21
In two-domain proteins, both domains usually play a direct
role in function. In proteins with more than two domains,
we sometimes find domains that are not directly involved
in function but link and orientate the domains that do carry
out functions. There are two examples in our data set,
entries 21 and 22.
Glycosyl Hydrolases
Examples of domains with linker roles are seen in some of
the glycosyl hydrolase proteins. Juers et al. (2000) and
Todd et al. (2001) have discussed the relationship of the
different functions of these proteins to their different
domain structures.
Glycosyl hydrolyzes act on both long-chain polysac-
charides and disaccharides. The members of the family
that act on polysaccharides usually have just one domain
(Figure 3A). These domains belong to the ‘‘Trans-glycosi-
dase’’ superfamily (c.1.8) and have a (b/a)8 barrel struc-
ture. The substrate-binding site is formed by a long groove
that extends across the C-terminal end of the barrel, as
shown in the drawing of (1/3)-b-glucanase (Varghese
et al., 1994) in Figure 3A.
Members of the glycosyl hydrolase family that act on
disaccharides have three or more domains that together
restrict the size of the substrate-binding site so that it
only recognizes disaccharides. One of these is b-glucu-92 Structure 15, 85–99, January 2007 ª2007 Elsevier Ltd All rronidase, which has three domains (Figure 3B). Another
is b-galactosidase, which has five domains (Figure 3C).
In b-glucuronidase, domain 3 is a member of the
‘‘Trans-glycosidase’’ superfamily. Domain 1 is a member
of the ‘‘Galactose binding’’ superfamily (b.18.1) and is ho-
mologous to a one-domain fucose-binding lectin. It has
loop regions that extend into the active site of domain 3
and thus restricts its size (Jain et al., 1996). These loop re-
gions are not involved in the generic galactose/cellulose-
binding function the domain exhibits elsewhere (Juers
et al., 1999).
Domain 2 links domain 1 to domain 3, and its packing
interactions determine the geometries of these two do-
mains (Figure 3B). Domain 2 has an immunoglobulin-like
fold (b.1.4) and is not involved in the active site or subunit
interactions.
b-galactosidase has evolved to become a more com-
plex protein in terms of both its structure (five domains)
and its function (Jacobson et al., 1994; Juers et al.,
2000). It can hydrolyze lactose, or it can convert it to allo-
lactose, which is then hydrolyzed. The first function is sim-
ilar to that of b-glucuronidase. The latter function is novel
and is believed to involve domain 5 (Juers et al., 1999).
The active site is formed by domains 1, 3, and 5. Domains
1–3 are homologous to, and have the same arrangement
as, the three domains that form b-glucuronidase. Domain
5 is a member of the ‘‘Galactose mutarotase-like’’ights reserved
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Genesis of New Functions via Domain CombinationFigure 4. The Iron Subunit of the Quinol-
Fumarate Reductase Iron Protein from
E. coli 1l0v
The diagram shows the electron transport path
between FAD and quinol via the three iron-
sulfur clusters in the iron subunit. Its N-terminal
‘‘2Fe-2S ferredoxin-like’’ domain is shown in
orange, and the C-terminal ‘‘a-helical ferre-
doxin’’ domain is shown in light blue. For the
purpose of clarity, only the FAD of the flavopro-
tein and proximal quinol (QP) transmembrane
subunit are shown. This figure was drawn
from 1l0v (Iverson et al., 2002).superfamily (b.30.5) and is found in galactose mutarotase
(Thoden et al., 2003) as a single-domain enzyme. Here, it
forms part of the active site by packing against the side
of domain 3 opposite to that where domain 1 packs
(Figure 3C). The residues that domain 5 contributes to
the active site are distinct from those in the active site of
galactose mutarotase, and they are located in a different
part of the fold; thus, these two activities appear to be un-
related.
Domain 4 is a homolog of the immunoglobulin-like do-
main 2. Its role is to link domains 3 and 5, and it determines
the geometry of the two domains: it makes no significant
contacts with other subunits and is not part of the active
site. Domain 2 in b-galactosidase, however, is not just
a linking domain as it is in b-glucuronidase: it contributes
to the structure of the active site in an adjacent subunit
in the oligomeric complex.
Domains that Regulate Enzyme Function: Entry 23
In our data set, there are two cases (entries 23 and 24) of
a one-domain enzyme having a homolog in a domain
combination in which additional domains in the combina-
tion regulate its function.
VHR and SHP-2 Tyrosine Phosphatases
Example of this subcategory are given by two tyrosine
phosphatases—the one-domain dual-specificity tyrosine
phosphatase VHR (Yuvaniyama et al., 1996) and the
three-domain tyrosine phosphatase SHP-2, which has
two SH2 domains (d.93.1) that regulate its activity (Hof
et al., 1998). In both enzymes, the homologous catalytic
domains (c.45.1) catalyze the removal of a phosphate
group from a tyrosine residue.Structure 15,In SHP-2, the two regulatory SH2 domains are linked to
the N terminus of the catalytic domain. In the inactive form
of the enzyme, loops from the most N-terminal SH2
domain bind and block the active site of the phosphatase
domain. Activation of the enzyme is caused by a phospho-
peptide ligand that binds the N-terminal SH2 domain at
a site that is quite distinct from that which interacts with
the active site of the phosophatase domain. The binding
of this peptide produces a conformational change in the
structure of the SH2 domain and shifts the relative posi-
tions of the loops that bind to the catalytic domain in the
inactive form. These shifts give the loops a geometry
that does not fit the active site and thus makes it acces-
sible to substrates (Hof et al., 1998).
Domain Combinations that Regulate DNA Binding:
Entry 25
There are two cases in our data set (entries 25 and 26) in
which the small-molecule recognition function of a sin-
gle-domain protein is used in a two-domain protein to reg-
ulate a transcription factor.
Molybdate/Tungstate-Binding Protein and
Molybdate-Dependent Transcription Factor
Example of this are given by two proteins that bind molyb-
date. The one-domain protein is the molybdate/tungstate-
binding protein (MOP, b.40.6), which is probably involved
in the storage and homeostasis of these ions (Schuttel-
kopf et al., 2002). This protein is a hexamer, and the bind-
ing site for molybdate is formed at the interface between
pairs of subunits.
The multidomain protein ModE is a molybdate-
dependent transcription factor that downregulates the85–99, January 2007 ª2007 Elsevier Ltd All rights reserved 93
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regulates production of molybdoenzymes (Schuttelkopf
et al., 2003). ModE is inactive in the absence of molybdate
and is activated by the binding of molybdate. The protein
is a dimer of identical subunits; the first domain of each
subunit is a member of the winged helix superfamily
(a.4.5), whose members are mostly involved in binding
DNA. It is joined by a short linker region to a tandem repeat
of MOP domains. Two molybdate-binding sites are
formed at the interface between two MOP domains of
different subunits.
Upon binding molybdate, the MOP domains undergo
conformational changes (Schuttelkopf et al., 2003). These
are transmitted to the linker regions, which, in turn, trans-
mit them to the winged helix domains. The effect of these
changes is to alter the relative positions of the two DNA
recognition helices in the winged helix domain. Relative
to the inactive form, the helices are moved 2 A˚ closer
together (Schuttelkopf et al., 2003). This change in their
relative orientation allows them to bind to the DNA tran-
scription site.
Gene Fusions that Form Bifunctional Enzymes:
Entry 32
Another category in which function is conserved subse-
quent to domain combination involves pairs of genes
that are separate proteins in some organisms fusing to
form a bifunctional enzyme in other organisms. The 8
cases (from 16 single-domain proteins) in our data set
are found in entries 27–34. Most of these involve combina-
tions of proteins that carry out sequential steps in a path-
way. Here, we describe a more complex example.
6-Phosphofructo-2-Kinase/Fructose-2,
6-Bisphosphatase
6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase
(Hasemann et al., 1996) has two domains. The reaction
catalyzed by the first domain is the reverse of that carried
out by the second. The first domain (c.37.1) catalyzes the
synthesis of fructose-2,6-bisphosphate, by the addition of
phosphate to fructose-6-phosphate, and the second do-
main (c.60.1) carries out its degradation by the removal
of this phosphate. Homologs of both domains are found
as one-domain proteins that have similar functions: phos-
phoribulokinase (Harrison et al., 1998) and prostatic acid
phosphatase (Ortlund et al., 2003).
6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase
plays a crucial role in glucose homeostasis. In the absence
of regulation, one domain in this protein would reverse the
action of the other. To prevent this, the actual balance
of the two activities is regulated by various metabolites
becoming inhibitors at particular concentrations, or by
phosphorylation, which affects both kinase and bisphos-
phatase activities via communication between domains
(Pilkis et al., 1995).
Separation in the Multidomain Protein of Functional
Roles Found in a One-Domain Protein: Entry 37
There are four cases (entries 35–38) in the data set in
which one of the activities found in the one-domain protein94 Structure 15, 85–99, January 2007 ª2007 Elsevier Ltd All rigis transferred to other domains that combine with the
homolog of the one-domain protein.
FokI and EcoRV
Example of this are given by the restriction enzymes
EcoRV (Kostrewa and Winkler, 1995) and FokI (Wah
et al., 1997). EcoRV is a one-domain protein (c.52.1) from
E. coli that recognizes the DNA sequence 50-GATATC-30
and cleaves it in the center.
FokI (Wah et al., 1997) has three domains that belong to
the winged helix superfamily (a.4.5), most of whose
members are involved in DNA recognition, and, at the C
terminus, a catalytic domain that is homologous to EcoRV.
FokI recognizes the DNA sequence 50-GGATG-30, but it
cleaves DNA nonspecifically at a short distance from
that sequence. The structure of a FokI-DNA complex
(Wah et al., 1997) shows that the first two of the three
winged helix domains are almost entirely responsible for
the recognition of the specific DNA sequence. The third
winged helix domain acts as a linker to the fourth catalytic
domain. In isolation, the FokI catalytic domain only binds
DNA weakly and nonspecifically (Li et al., 1992).
Locating DNA-binding specificity and catalysis on differ-
ent domains allows mutations in the recognition domain to
change sequence specificity in a manner that would not
affect the existing functionality of the catalytic domain. It
also allows recombination with domains that have a dif-
ferent DNA sequence specificity or a different catalytic
mechanism. Indeed, Chandrasegaran and coworkers have
carried out several experiments using the catalytic domain
of FokI in combination with different DNA-binding domains
to produce chimeric restriction enzymes (Kim et al., 1996).
Domains Whose Combination Allows Them to
Function in New Contexts: Figure 4 and Entry 39
There are 11 cases in our data set (entries 21b, 21c, 25b,
26b, 39–42, and 45b) in which a one-domain protein and
a homolog in a multidomain protein conserve their func-
tions but carry them out in different structural contexts.
Ferredoxin and Quinol-Fumarate Reductase
Ferredoxin (d.15.4) (Morales et al., 1999), a soluble one-
domain protein, contains a [2Fe-2S] iron cluster that is
used to transport electrons between different redox
centers. A homolog of ferredoxin, combined with another
domain, is found in one of the subunits of the membrane
protein quinol-fumarate reductase (Iverson et al., 2002).
Quinol-fumarate reductase (QFR) catalyzes the terminal
step of anaerobic respiration. It has four subunits. Two of
these reside in the membrane and accept electrons do-
nated by menaquinol. Three iron-sulfur clusters in the third
domain then transport these electrons to FAD in the fourth
subunit, where they are used to reduce fumarate.
The third subunit has two domains (Figure 4): one do-
main is a homolog of ferredoxin with one [2Fe-2S] cluster,
and the other domain is a member of the a-helical ferre-
doxin superfamily (a.1.2) and has two [4Fe-4S] clusters.
The ferredoxin domain in this subunit does not transport
electrons between proteins, as it does in the one-domain
homologs, but forms part of a pathway that transports
electrons within a protein complex.hts reserved
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Domain Combination: Figure 5 and Entry 38
There are four cases in the data set in which the catalytic
activity present in a one-domain protein is not present in
a homolog that is part of a domain combination. In two
of these, some other functions are conserved (entries 5b
and 38b), and in the other two, there is a complete change
in function (entries 43 and 44).
Copper, Zinc Superoxide Dismutase and the Copper
Chaperone of Superoxide Dismutase
Examples of this category are given by the one-domain
protein superoxide dismutase (SOD) (Tainer et al., 1982)
and by the two-domain copper chaperone of SOD (CCS)
(Lamb et al., 2001). Both have domains that belong to
the ‘‘Superoxide dismutase superfamily’’ (b.1.8). SOD it-
self is a homodimer that catalyzes the conversion of super-
oxide radicals to oxygen and hydrogen peroxide. To carry
out this function, its active site requires both copper and
zinc ions. The copper ions are provided by CCS (Figure 5).
The central region of CCS is formed by a domain that is
homologous to SOD, but is not catalytic: it lacks both the
metal-binding sites and the catalytic residues. It does,
however, retain the ability to form a dimer with a SOD
monomer in a manner that is the same as that of a SOD
dimmer. At the N terminus of CCS, there is a domain
that belongs to the ‘‘Heavy metal-associated’’ superfamily
(d.58.17) and is homologous to the one-domain protein
Hah1 Metallochaperone that binds and transports copper
(Wernimont et al., 2000). At its C terminus, there is a 27
residue extension that is also able to bind copper (Lamb
et al., 2001). CCS supplies copper to the SOD enzyme
by its central domain first binding to a SOD monomer.
The copper ion is then transferred from the N-terminal
heavy metal-associated domain to the C-terminal exten-
sion, which, in turn, transfers the copper ion to the active
site of SOD (Lamb et al., 2001).
Thus, in this example, the domain in CCS that is homol-
ogous to the SOD domain does not have the catalytic
properties of the latter but has retained its dimerization
properties. This property is used to facilitate the process
that puts copper into the active site of SOD.
Gain of Catalytic Activity in a Domain
Combination: Entry 15
There are three cases in the data set in which a one-
domain protein that is not catalytic has a homolog in a
domain combination that is catalytic (entries 15b, 19b,
and 36b).
Phosphatidylinsoitol Transfer Protein and the
a Subunit of Naphthalene 1,2-Dioxygenase
Examples of this category are provided by the one-do-
main phoshatidylinsoitol transfer protein (PITP) (Yoder
et al., 2001) and the two-domain a subunit of naphthalene
1,2-dioxygenase (NDO) (Kauppi et al., 1998).
PITP is a member of the ‘‘Bet v1-like’’ superfamily
(d.129.3) and has no catalytic activity: it mediates the ex-
change of phoshatidylinositiol and phosphatidylcholine
molecules between different membranes. It has anStructure 15eight-stranded b sheet and three long a helices that
pack to form a large, long cavity between the b sheet
and the a helices. Phospholipids are accommodated in
this cavity, and their phosphate groups make hydrogen
bonds to polar residues at the back of the cavity (Yoder
et al., 2001).
NDO catalyzes the dihydroxylation of the aromatic com-
pound napthalenene to give cis-naphthalene dihydrodiol
and is an a3b3 hexamer. There is no evidence for the b
subunits being involved in catalysis. The a subunit has
two domains. At the N terminus, there is a [2Fe-2S]-bind-
ing Rieske domain that belongs to the ‘‘Iron-sulphur pro-
tein (ISP)’’ superfamily (b.33.1). It binds a [2Fe-2S] cluster
and transports electrons. At the C terminus, there is a cat-
alytic domain that is homologous to PITP. It has a large
central cavity that is similar to that in PITP, but it binds a
different substrate: napthalenene. At the back of this
cavity, there is a mononuclear iron that is linked by
hydrogen bonds to the Rieske domain of the adjacent
a subunit. The reaction is believed to involve dioxygen
binding to the mononuclear iron, followed by its conver-
sion to peroxide by electrons donated from the Rieske
domain ion cluster to the active site iron, and the attack
of the peroxide on the substrate (Carredano et al.,
2000).
Figure 5. Heterodimeric Structure of Copper, Zinc Super-
oxide Dismutase in Complex with Its Copper Chaperone 1jk9
The SOD enzyme is shown in orange in complex with its copper chap-
erone, which is shown in blue and red. The copper chaperone is com-
posed of two domains. The N-terminal domain of the chaperone is
shown in red and belongs to the ‘‘HMA, heavy metal-associated do-
main’’ superfamily. The C-terminal domain of the copper chaperone
is homologous to SOD and belongs to the ‘‘Cu,Zn superoxide dis-
mutase-like’’ superfamily. It conserves the ability to form a dimer
with SOD. The chaperone also has a C-terminal extension that packs
against SOD, which is thought to be involved in the mechanism that
loads copper into the SOD active site (Lamb et al., 2001). This figure
was drawn from 1jk9 (Lamb et al., 2001)., 85–99, January 2007 ª2007 Elsevier Ltd All rights reserved 95
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involves the creation of a catalytic active site, domain com-
bination, and the formation of oligomers. The formation of
the iron-binding site requires side chains different from
those in PITP, and these changes involve residues that are
not equivalent to those that bind the phosphate in PITP.
Other residue changes alter the shape of the cavity so that
naphthalene, rather than phoshatidylinositol, is bound.
Change in the Catalytic Reaction in Domain
Combination: Entry 17
In this category, there are two cases in which the reaction
catalyzed by the one-domain enzyme is quite different
from that of a homologous domain found in the domain
combination (entries 17b and 45a).
Zinc-b-Lactamase and Rubredoxin:
Oxygen Oxidoreductase
Examples of this category are the one-domain protein
Zn-b-lactamase (Carfi et al., 1995) and the two-domain
subunit of the dimeric protein Ruberdoxin: oxygen oxido-
reductase (ROO) (Frazao et al., 2000). Zn-b-lactamase is
a member of the ‘‘Metalo-hydrolase/oxidoreductase’’
superfamily (d.157.1). It catalyzes the hydrolysis of the b-
lactam ring of the penicillin and cephalosporin antibiotics.
ROO is part of the pathway that protects anaerobic or-
ganisms from oxygen by catalyzing its reduction to water.
The N-terminal catalytic domain of ROO is homologous to
Zn-b-lactamase. In ROO, however, the zinc ion is replaced
by di-iron. The second domain of ROO is a member of the
same superfamily as the one-domain protein flavodoxin
(c.23.5) and similarly binds flavin mononucleotide (FMN).
Ruberdoxin supplies electrons to the FMN in the second
ROO domain, which then passes them to the di-iron site
in the first domain of the adjacent subunit. These elec-
trons, together with H+ ions, then reduce the oxygen
bound by the di-iron to water.
The overall structures of Zn-b-lactamase and the ho-
mologous domain in ROO are very similar. The change
in their function is mainly produced by structural changes
in two regions. The first region is the pocket adjacent to
the zinc-binding site that is used by Zn-b-lactamase to
bind penicillin and cephalosporin substrates. This pocket
is not found in ROO, where the equivalent region is filled by
insertions in the ROO structure and by domain-domain
contacts (Frazao et al., 2000). The second region con-
cerns the zinc ion bound in the lactamases and the
di-iron group bound in ROO. Six residues bind metal
ions in both structures, and they come from equivalent
sites and have a similar geometry. There are, however, dif-
ferences in the identity of two side chains: Glu in place of
His and Asp in place of Cys:
ROO: H-X-E-X-D-X62-H-X18-D-X60-H
Zn-b-lactamase: H-X-H-X-D-X58-H-X18-C-X41-H.
These differences favor the binding of di-iron in ROO and
a zinc ion in b-lactamase (Frazao et al., 2000). Note that in
ROO, the substitution of zinc for di-iron provides a group
that both binds the substrate and carries out catalysis.96 Structure 15, 85–99, January 2007 ª2007 Elsevier Ltd All rigCONSERVATION AND CHANGE OF FUNCTION
OF HOMOLOGOUS DOMAINS
In the previous sections of the paper, we have described in
some detail the extent to which the functions found in one-
domain proteins are conserved, modified, or changed in
homologous domains found in multidomain proteins.
These descriptions cover only one-quarter of the entries
in Table 1. Here, we describe the extent of conservation
and change in all entries.
Here, we have examined 46 multidomain proteins. Of
these, 38 are formed by 2 domains, 6 by 3, 1 by 4, and 1
by 5. These 46 multidomain proteins are composed of
103 domains belonging to 1 of 83 different superfamilies.
For 61 of these superfamilies, structures are known for
both one-domain and multidomain proteins. At the pres-
ent time, the domains in the other 22 superfamilies are
only known in structures in which they form combinations
with domains from other superfamilies. Overall, our data
set has a total of 70 unique pairs of one- and multidomain
proteins that have a homologous domain in common (see
Table 1).
The one-domain proteins that are homologous to those
in multidomain proteins have a variety of functions: 44 are
enzymes, 8 transport electrons, 6 transport ions or small
molecules, 17 bind nucleic acids (including 7 of the en-
zymes), 1 is a chaperone, and 1 forms dimers. The previ-
ous sections of the paper, Table 1, and the Supplemental
Data describe the extent of the conservation and/or
change in function of the homologous domains found in
the one- and multidomain proteins.
Out of a total of 70 unique pairs of single- and multido-
main proteins that have a homologous domain in com-
mon, the functions found in the one-domain proteins are
conserved, entirely or largely, in three-quarters of the
domains that form the multidomain proteins; just under
one-sixth have functions that are very different from those
found in their one-domain homologs, and the remainder
have partial conservation of functions (details of the data
that provide these proportions are given in the Supple-
mental Data).
We measured the global sequence identity between all
70 pairs of homologous domains by using the alignment
program Needle (Needleman and Wunsch, 1970; Rice
et al., 2000) and domain sequences available from the
ASTRAL database (Chandonia et al., 2004). We found
that the sequence identity of the homologous pairs of
domains ranges between 1% and 42%. Most values
cluster toward the lower end of this range, and the aver-
age value for the 70 pairs is 14.5%. The domains that
conserve their functions have an average sequence iden-
tity of 15%. If we consider only those pairs in which there
has been partial functional conservation, the average se-
quence identity is 14%. For the cases in which the func-
tions of the homologous domains are not conserved, the
average sequence identity is 12.5%. Figure 6 shows the
spread of the sequence identities of the pairs whose
function is conserved, partially conserved, and not
conserved.hts reserved
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conservation and change cannot be attributed on the
basis of a simple sequence identity cut-off. Of course,
the data set considered here is small, and this conclusion
needs to be confirmed by more extensive analysis. How-
ever, we should also note that the extent of the functional
conservation described here may underestimate its true
extent because we have confined our comparisons to pro-
teins for which there are known structures. There may be
one-domain proteins whose structures are unknown at
present but whose functions are similar to their homologs
in the multidomain proteins.
The extent of functional conservation described here is
very different from that described by Hegyi and Gerstein
(2001). They analyzed 70 superfamilies that occur in both
one-domain and multidomain proteins and found that
only 14 superfamilies had the ‘‘same’’ function. The reason
for the difference is that they used only the conservation of
the first three EC numbers and synonymous SWISS-PROT
keywords to assign function. In this study, we have deter-
mined in molecular detail the function of each domain in the
one- and multidomain proteins and were thus able to find
similarities that were missed by their procedure.
Conclusion: A Grammar for Domain Combinations
Here, we have discussed how different combinations of
domains from different superfamilies produce new func-
tions. In some ways, this process is analogous to how,
in language, word combinations function.
Here, we frequently find that the general function of the
homolog of the one-domain protein in the multidomain
protein has been conserved but has been modified or
made more specific. This is achieved by placing the ho-
mologous domain into a new domain context or ‘‘syntax,’’
in which an additional domain serves to expand, alter, or
modulate its functionality. Syntax governs the arrange-
ments in a sentence of words that individually have partic-
ular meanings and taken together make ‘‘sense’’; this can
be modified further by the replacement or the addition of
other suitable words. The addition of unsuitable words
will produce nonsense.
Figure 6. Graph Showing the Extent of the Sequence Identity
of Homologous Domains in One- and Multidomain Proteins
Homologous domains falling into the conserved, partial, and noncon-
served categories are indicated.Structure 15, 8In the small number of cases in which the functions of
the domain are totally changed, we find that the common
scaffold of the protein domain has been adapted to carry
out a different, unrelated reaction or bind a different, unre-
lated ligand. This is a redesign of the protein’s function
through progressive mutation of the domain itself to gen-
erate quite different functions. It can be thought of as
a change in semantics, i.e., that the function or ‘‘meaning’’
of the domain itself has changed. This is found in words
that have quite different meanings according to their con-
text: e.g., ‘‘she is a red’’ (i.e., a communist); ‘‘the pillar-box
is red’’ (i.e., is painted red).
Another property also observed during this study that is
characteristic of the development of natural languages is
the generation of discreteness (Senghas et al., 2004). In
four cases (entries 35a, 36a, 37a, and 38a), we observed
that two distinct functions previously carried out by
a one-domain protein have been separated into discrete
functions carried out by different domains in the multido-
main proteins. This process can be considered advanta-
geous to the domain combination; by the distributing of
a specific function to dedicated domains, the protein
may achieve greater molecular efficiency in terms of
ligand-protein interactions. Moreover, now that previously
unified functions are uncoupled in the two-domain state,
the possibility of acquiring enhanced, or altered, function-
ality via separate mutation of domains, without mutual im-
pact on existing functionality, is greatly increased. In addi-
tion, the ability to recombine, with synonymous domains
carrying out the same function, but being of a different
superfamily (as in the case of the DNA-binding domains
of FokI), is greatly enhanced by this dichotomy.
These features—change in syntax and semantics and
the generation of discreteness—are all properties of a
natural grammar of domain combination that determines
the assembly of functionally coherent combinations of do-
mains and gives rise to more complex protein functions.
This grammar is a consequence of the selection of combi-
nations of domains that make ‘‘sense’’ functionally and
deletion of those that are ‘‘nonsense.’’
These considerations are useful in trying to predict the
functions of novel domain combinations for which there
is no experimental evidence for their function. Thus, a
novel combination of two domains that are homologous
to a small-molecule-binding protein and to a DNA-binding
protein would suggest that in this protein the activity of the
DNA-binding domain was being regulated by the other
domain binding a small molecule that may or may not be
the same as that bound to the one-domain homolog. Con-
versely, in a novel combination like entry 17 in Table 1,
where one domain is homologous to Zn metallo-b-lacta-
mase and the other to flavodoxin, it is difficult to see
how, if their functions are conserved, the combination
could make coherent use of them. Here, it would be rea-
sonable to assume that at least one domain has changed
its function.
To predict the function of novel proteins, by using an
approach like that outlined in the previous paragraph, re-
quires a comprehensive description of how the properties5–99, January 2007 ª2007 Elsevier Ltd All rights reserved 97
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functions of multidomain proteins (Bashton, 2004).
Here, we have analyzed only a very small subset of the
different domain combinations found in proteins. New
structures will certainly include those that have types of
domain combination that go well beyond those listed in
Table 2. We would expect, however, that the grammatical
trends and functional modifications observed here will
hold true for a much larger data set.
Supplemental Data
Supplemental Data include Table S1, detailing the functional conser-
vation and change in all 45 pairs of one-domain and multidomain
proteins in full, as well as details of the conservation and change of
function of homologous domains as text and are available at http://
www.structure.org/cgi/content/full/15/1/85/DC1/.
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